Clinical Trial Update: Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 safety study evaluating the combination of dacarbazine and bortezomib in patients with melanoma and soft tissue …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Soft Tissue Sarcoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Velcade (bortezomib)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Melanoma, Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED